UNICAMP/CEMICAMP Researchers Stand Out at the 29th SOGESP Congress

The 29th Congress of the Society of Obstetrics and Gynecology of the State of São Paulo (SOGESP) brought significant recognition to the researchers from the Department of Tocoginecology at the Faculty of Medical Sciences of the State University of Campinas (UNICAMP). Three studies developed by UNICAMP/CEMICAMP researchers were awarded, standing out in the field of Gynecology.

1st place: The study “Complications Related to the Frequency of Vaginal Pessary Hygiene in Women with Genital Prolapse: Randomized Clinical Trial” (G312) achieved the highest position in the field of Gynecology. This study, conducted by Cássia Raquel Teatin Juliato, Geovanna Volta Giorgenon, Luiz Gustavo Oliveira Brito, and Edilson Benedito de Castro, investigated the relationship between the frequency of vaginal pessary hygiene and the occurrence of complications in women with genital prolapse.

2nd place: The study “Gene Expression Associated with Unfavorable Vaginal Bleeding in Women Using the Subdermal Etonogestrel Contraceptive Implant: A Prospective Study” (G240) was also widely recognized, securing 2nd place. Led by Flavia Rocha Torelli and co-authored by Raquel Peres, Ilza Maria Urbano Monteiro, Iscia Terezinha Lopes Cendes, Luis Guillermo Bahamondes, and Cássia Raquel Teatin Juliato, the study offers new insights into the biological mechanisms related to vaginal bleeding in users of the etonogestrel implant.

4th place: Another awarded study was “Comparison of Unilateral vs. Bilateral Tibial Nerve Stimulation in Women with Overactive Bladder Syndrome: Randomized Clinical Trial” (G237), which secured 4th place. Developed by Edilson Benedito de Castro, Cássia Raquel Teatin Juliato, Leticia Martinelli Galhardo, Geovanna Volta Giorgenon, Luiz Gustavo Oliveira Brito, and Marina Rótoli da Silva, the study compared the efficacy of unilateral and bilateral tibial nerve stimulation approaches for the treatment of overactive bladder syndrome.

These awards reinforce UNICAMP’s commitment to excellence in scientific research and its contribution to advancing women’s health.